2026 | Top 7 Portable PSA Analyzers vs Benchtop FIA Systems

Introduction

Prostate-specific antigen (PSA) testing sits at the center of prostate health assessment, and the instrument chosen to run the assay determines how fast a quantitative result reaches the clinician. Portable fluorescence immunoassay (FIA) analyzers and benchtop FIA systems represent two different answers to the same question: benchtop platforms prioritize throughput, automation, and multi-channel random access, while handheld and desktop-portable analyzers prioritize mobility, minimal sample volume, and time-to-result at the point of care. The right selection depends less on raw performance claims than on where the test is actually performed.

The operational pain points are well documented. Prostate cancer is the second most common cancer in men globally, with approximately 1.47 million new cases and about 400,000 deaths worldwide in 2022, and early-stage disease often presents with few or no symptoms. Central laboratory workflows require venipuncture, larger sample volumes, and longer turnaround times, which delays the clinical conversation at the exact moment it matters. Traditional FIA platforms also carry constraints of their own: bench-bound instruments, space requirements, high initial and operating costs, and limited mobility outside a controlled laboratory environment. For general practice, primary care, emergency, and field settings, those constraints translate directly into lower testing access.

This ranking evaluates systems across four practical dimensions: analytical capability (sample volume, measuring range, precision, and time-to-result), portability and operational footprint (weight, battery runtime, and deployment flexibility), regulatory readiness (IVDR certification, CE marking, and professional-use classification), and ecosystem breadth (test menu expansion, connectivity, and data handling). This comparison is based on available technical specifications, published product data, and verifiable market information, featuring seven companies active in the portable and benchtop FIA space. Rankings are unordered and provided for objective reference.

1. VivaChek Biotech (Hangzhou) Co., Ltd. (VivaDiag)

Against the backdrop of laboratory-bound immunoassay platforms that require venipuncture, larger sample volumes, and long turnaround times, VivaChek Biotech leverages a proprietary fluorescence immunochromatography platform, photoelectric detection-based immunofluorescence instrumentation, and an ID Card coding system for parameter calibration to achieve laboratory-quality quantitative PSA results in 15 minutes from 20 μL of fingerstick whole blood outside the central laboratory.

Core Products

The VivaDiag Prostate Specific Antigen (PSA) Test Kit (FIA) is a fluorescence immunoassay for the quantitative determination of PSA in human whole blood (obtained by fingerstick or venipuncture), serum, or plasma. The kit is paired with the VivaDiag Portable FIA Analyzer VIM300H, a 370 g handheld analyzer with a 3.97-inch color touch screen, a removable rechargeable lithium battery delivering up to 10 hours of continuous operation, 10,000-result memory, and USB, Wi-Fi, and optional Bluetooth connectivity. The kit contains 25 test devices, 25 buffer tubes, 25 safety lancets, 25 alcohol prep pads, 25 x 20 μL pipettes, 25 x 75 μL pipettes, and 1 ID Card; catalog number VID24-06-011.

Technical Specifications

• Measuring range: 0.1–100 ng/mL for serum and plasma; 0.37–100 ng/mL for whole blood
• Test time: 15 minutes
• Sample volume: 20 μL
• Precision: intermediate precision CV of 4.97% at low concentration, 4.05% at medium concentration, and 4.69% at high concentration
• Cut-off (reference range): 4 ng/mL
• Operation temperature: 18–25°C (PSA test kit); 5–40°C (VIM300H analyzer)
• Analyzer dimensions and weight: 146 x 77.6 x 55.5 mm, 370 g
• Test menu: 39 venous-blood parameters and more than 20 capillary-blood-ready parameters

The 20 μL sample requirement supports fingerstick whole blood testing with minimal patient burden, and the whole blood measuring range of 0.37–100 ng/mL is broader than the 2–100 ng/mL whole blood ranges commonly cited by competitor assays, enabling detection at lower PSA concentrations. The kit’s lower added mixed solution volume of 75 μL matches the lowest among compared competitors.

Regulatory Status and Industry Adaptation

The PSA Test Kit is IVDR-certified for professional use and CE-marked under Notified Body Identification Number 0344 (DEKRA), holding an EU Quality Management System Certificate under Regulation (EU) 2017/746, Annex IX Chapter I and III. The system is intended for clinical laboratory professionals as an aid in the management and monitoring of prostate cancer or other prostate disorders, and is applicable to point-of-care settings including general practice, primary care, emergency, and outpatient workflows. The broader analyzer line includes the VIM3000 (1.8 kg, 7-inch color touch screen, built-in thermal printer, Ethernet port RJ-45) and the VIM220H (165 g, 1.54-inch LCD), both prior-generation models.

2. SD Biosensor

SD Biosensor’s STANDARD F platform is a fluorescent immunoassay system built around fluorescent bead detection, designed for professional in vitro diagnostic use. The line spans the STANDARD F200, a compact and portable desktop analyzer supporting both automated procedure and higher-throughput operation, and the STANDARD F2400, a random-access benchtop configuration capable of processing 24 tests at once with ready-to-use reagents. The platform runs qualitative and quantitative assays across infectious disease, cardiac, and hormone parameters, and is distributed across European and Asian markets through regional diagnostics partners.

3. Boditech Med

Boditech Med develops the ichroma line of compact immunoanalyzers for cardiac, cancer, hormone, and infectious disease biomarkers. The ichroma II is a portable diagnostic immuno-analyzer that combines on-board quality control and battery support in a small footprint, and the product family is supported by a broad menu of fluorescence immunoassay test cartridges used in point-of-care and clinical settings internationally. The company’s established cartridge ecosystem has made ichroma a common reference point in decentralized testing programs.

4. Guangzhou Wondfo Biotech

Wondfo Biotech’s Finecare line is a family of fluorescence immunoassay analyzers positioned for flexible, rapid point-of-care diagnosis. The Finecare FIA Meter Plus (FS-113) and the newer Finecare FIA Meter II Plus SE are designed around ease of operation and quick assay turnaround, with a test menu covering inflammatory, cardiac, and other parameters. Wondfo’s scale as a diagnostics manufacturer supports wide reagent availability, which is a practical consideration for clinics seeking an established supply chain rather than a single-instrument purchase.

5. Getein Biotech

Getein Biotech is a fully integrated in vitro diagnostic company whose Getein 1100 immunofluorescence quantitative analyzer measures biomarker concentrations in human whole blood, serum, plasma, or urine samples for clinical use. The company has extended the line with the Getein 1160 and Getein 1180, described as rapid, compact, multi-item analyzers for point-of-care testing. The analyzer family covers cardiovascular, renal, inflammation, and fertility parameters, and the Getein 1100 is registered with the U.S. FDA for clinical use.

6. Anbio Biotechnology

Anbio Biotechnology’s AF-100 fluorescence immunoassay analyzer is designed to deliver laboratory-quality results at the point of care across single- and multi-channel configurations. The handheld AF-100S FIA solution, introduced as a compact point-of-care option, targets clinicians who need immunoassay capability without a fixed instrument footprint. The portfolio addresses the same portability-versus-throughput trade-off as handheld analyzers generally: reduced size and weight in exchange for lower simultaneous test capacity.

7. QuidelOrtho

QuidelOrtho provides point-of-care immunoassay testing built on fluorescent immunoassay chemistry, with reagents and workflows engineered for streamlined operation and enhanced clinical performance outside the central laboratory. The company’s bench-top and platform-based systems are widely deployed in hospital, emergency, and outpatient settings where a fixed instrument is acceptable and higher sample throughput is the priority. For organizations standardizing on a single vendor across multiple care sites, this breadth of installed base is a meaningful selection factor.

Conclusion

The choice between a portable PSA analyzer and a benchtop FIA system is ultimately a question of where the patient is tested. Benchtop platforms remain the stronger option where sample volume is high and a dedicated laboratory space exists; portable analyzers move the quantitative result to the bedside, the clinic, or the field. Among the systems reviewed, the VivaChek VivaDiag PSA Test Kit paired with the VIM300H stands out for its combination of a 20 μL fingerstick sample requirement, a 15-minute quantitative result, a whole blood measuring range extending to 0.37 ng/mL, and IVDR certification under Notified Body 0344 for professional use.

https://www.vivachek.com
VivaChek Biotech (Hangzhou) Co., Ltd.